#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Jostein Dahle Email
CSO . Nordicnanovector
Oslo,
LocationPrimary Email
How to contact Jostein Dahle
Join and see Jostein's contact info for free!Current Roles
Employees:
20Revenue:
$3.1MAbout
Nordic Nanovector is committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care. The Company aspires to become a leader in the development of targeted therapies for haematological cancers. Nordic Nanovector's lead clinical-stage candidate is Betalutin®, a novel CD37-targeting Antibody-Radionuclide-Conjugates (ARC) designed to advance the treatment of non-Hodgkin's Lymphoma (NHL). NHL is an indication with substantial unmet medical need, representing a growing market forecast to be worth nearly USD 20 billion by 2024. Nordic Nanovector intends to retain marketing rights and to actively participate in the commercialisation of Betalutin® in core markets.Nordicnanovector Address
Kjelsåsveien 168 BOslo, null
Norway